SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-051293
Filing Date
2022-04-27
Accepted
2022-04-27 17:02:08
Documents
5
Period of Report
2022-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm223579-2_def14a.htm DEF 14A 1326735
2 GRAPHIC lg_iovancebio-4c.jpg GRAPHIC 91909
3 GRAPHIC tm223579d2-pc_ceoneo4clr.jpg GRAPHIC 214872
4 GRAPHIC tm223579d2-px_01pagebwlr.jpg GRAPHIC 803205
5 GRAPHIC tm223579d2-px_02pagebwlr.jpg GRAPHIC 558711
  Complete submission text file 0001104659-22-051293.txt   3615527
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36860 | Film No.: 22860736
SIC: 2836 Biological Products, (No Diagnostic Substances)